SignalCorporate
MannKind anticipates $1B in revenue from United Therapeutics deal from 2027-2030 as it targets Q4 profitability
MannKind projects $1B revenue from United Therapeutics deal 2027–2030, targeting Q4 profitability.
What changed
MannKind projects $1B revenue from United Therapeutics deal 2027–2030, targeting Q4 profitability.
Why it matters
MannKind projects $1B revenue from United Therapeutics deal 2027–2030, targeting Q4 profitability. — impact context not separately stored; see What changed.